CoChat

Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting

Open access

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Background Treatment guidelines for aphasia recommend intensive speech and language therapy for chronic (≥6 months) aphasia after stroke, but large-scale, class 1 randomised controlled trials on treatment effectiveness are scarce. We aimed to examine whether 3 weeks of intensive speech and language therapy under routine clinical conditions improved verbal communication in daily-life situations in people with chronic aphasia after stroke.Methods In this multicentre, parallel group, superiority, open-label, blinded-endpoint, randomised controlled trial, patients aged 70 years or younger with aphasia after stroke lasting for 6 months or more were recruited from 19 inpatient or outpatient rehabilitation centres in Germany. An external biostatistician used a computer-generated permuted block randomisation method, stratified by treatment centre, to randomly assign participants to either 3 weeks or more of intensive speech and language therapy (≥10 h per week) or 3 weeks deferral of intensive speech and language therapy. The primary endpoint was between-group difference in the change in verbal communication effectiveness in everyday life scenarios (Amsterdam-Nijmegen Everyday Language Test A-scale) from baseline to immediately after 3 weeks of treatment or treatment deferral. All analyses were done using the modified intention-to-treat population (those who received 1 day or more of intensive treatment or treatment deferral). This study is registered with ClinicalTrials.gov, number NCT01540383.Findings We randomly assigned 158 patients between April 1, 2012, and May 31, 2014. The modified intention-to-treat population comprised 156 patients (78 per group). Verbal communication was significantly improved from baseline to after intensive speech and language treatment (mean difference 2·61 points [SD 4·94]; 95% CI 1·49 to 3·72), but not from baseline to after treatment deferral (-0·03 points [4·04]; -0·94 to 0·88; between-group difference Cohen's d 0·58; p=0·0004). Eight patients had adverse events during therapy or treatment deferral (one car accident [in the control group], two common cold [one patient per group], three gastrointestinal or cardiac symptoms [all intervention group], two recurrent stroke [one in intervention group before initiation of treatment, and one before group assignment had occurred]); all were unrelated to study participation.Interpretation 3 weeks of intensive speech and language therapy significantly enhanced verbal communication in people aged 70 years or younger with chronic aphasia after stroke, providing an effective evidence-based treatment approach in this population. Future studies should examine the minimum treatment intensity required for meaningful treatment effects, and determine whether treatment effects cumulate over repeated intervention periods.Funding German Federal Ministry of Education and Research and the German Society for Aphasia Research and Treatment.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(17)30067-3

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 31 references

Cited by

See all 450

Metadata

Authors
Breitenstein, C., Grewe, T., Flöel, A., Ziegler, W., Springer, L., Martus, P., Huber, W., Willmes, K., Ringelstein, E. B., Haeusler, K. G., Abel, S., Glindemann, R., Domahs, F., Regenbrecht, F., Schlenck, K.-J., Thomas, M., Obrig, H., de Langen, E., Rocker, R., Wigbers, F., Rühmkorf, C., Hempen, I., List, J., Baumgaertner, A., Villringer, A., Bley, M., Jöbges, M., Halm, K., Schulz, J., Werner, C., Goldenberg, G., Klingenberg, G., König, E., Müller, F., Gröne, B., Knecht, S., Baake, R., Knauss, J., Miethe, S., Steller, U., Sudhoff, R., Schillikowski, E., Pfeiffer, G., Billo, K., Hoffmann, H., Ferneding, F.-J., Runge, S., Keck, T., Middeldorf, V, Krüger, S., Wilde, B., Krakow, K., Berghoff, C., Reinhuber, F., Maser, I., Hofmann, W., Sous-Kulke, C., Schupp, W., Oertel, A., Bätz, D., Hamzei, F., Schulz, K., Meyer, A., Kartmann, A., Som, O., Schipke, S.-B., & Bamborschke, S.
Affiliations
  • University of Münster (DE)
  • Hochschule Fresenius (DE)
  • Universität Greifswald (DE)
  • Ludwig-Maximilians-Universität München (DE)
  • Universitätsklinikum Aachen (DE)
  • University of Tübingen (DE)
  • University of Manchester (GB)
  • München Klinik Bogenhausen (DE)
  • Philipps University of Marburg (DE)
  • Max Planck Institute for Human Cognitive and Brain Sciences (DE)
  • Center for Stroke Research Berlin (DE)
  • Charité – Universitätsmedizin Berlin (DE)
Corresponding author
Breitenstein, Caterina
Venue
The Lancet
Publisher
Elsevier BV
Published
2017-04
Volume
389
Issue
10078
Pages
1528-1538
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2592854460
Cited by
387
References
31
Citations by year
2026: 34 · 2025: 40 · 2024: 45 · 2023: 40 · 2022: 40 · 2021: 69 · 2020: 45 · 2019: 36 · 2018: 22 · 2017: 15
FWCI
18.53
Type
journal article
Language
en
Licence
  • other-oa
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • RWTH Publications (RWTH Aachen) (submittedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion, other-oa)
  • MPG.PuRe (Max Planck Society) (submittedVersion)
Funders
Bundesministerium für Bildung und Forschung (01GY1144)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neurobiology of Language and Bilingualism
  • Health Sciences › Medicine › Rehabilitation › Stroke Rehabilitation and Recovery
  • Social Sciences › Psychology › Developmental and Educational Psychology › Language Development and Disorders
Keywords
chronic aphasia, stroke, treatment deferral, verbal communication, everyday language, aphasia rehabilitation, treatment effectiveness, inpatient rehabilitation
MeSH terms
Stroke Rehabilitation, Adolescent, Adult, Aged, Aphasia, Chronic Disease, Humans, Language Therapy, Middle Aged, Speech Therapy, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting. https://app.cochat.ai/papers/10.1016/s0140-6736(17)30067-3
The paper
Breitenstein, C., Grewe, T., Flöel, A., Ziegler, W., Springer, L., Martus, P., Huber, W., Willmes, K., Ringelstein, E. B., Haeusler, K. G., Abel, S., Glindemann, R., Domahs, F., Regenbrecht, F., Schlenck, K.-J., Thomas, M., Obrig, H., de Langen, E., Rocker, R., . . . Bamborschke, S. (2017). Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting. The Lancet. https://doi.org/10.1016/s0140-6736(17)30067-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.